1. Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits
   Slobodan P. Rendic et al, 2018, Drug Metabolism Reviews CrossRef
2. Insulin/IGF-1R, SIRT1, and FOXOs Pathways—An Intriguing Interaction Platform for Bone and Osteosarcoma
   Consolato Sergi et al, 2019, Frontiers in Endocrinology CrossRef
3. Regulation of aromatase in cancer
   Deborah Molehin et al, 2021, Molecular and Cellular Biochemistry CrossRef
4. Function of microRNA‑141 in human breast cancer through cytotoxic CD4+ T cells regulated by MAP4K4 expression
   Qing Zhang et al, 2018, Molecular Medicine Reports CrossRef
5. Leptin stimulates aromatase in the growth plate: limiting catch-up growth efficiency
   Majdi Masarwi et al, 2018, Journal of Endocrinology CrossRef
6. Systems biology–based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma
   Lei Huang et al, 2018, Science Translational Medicine CrossRef
7. A candidate pathogenic gene, zinc finger gene 217 (ZNF217), may contribute to polycystic ovary syndrome through prostaglandin E2
   Junyu Zhai et al, 2020, Acta Obstetricia et Gynecologica Scandinavica CrossRef
8. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue
   Céline Gérard et al, 2018, Molecular and Cellular Endocrinology CrossRef
9. A review and update for registered clinical studies of stem cells for non-tumorous and non-hematological diseases
   Jianhua Chen et al, 2021, Regenerative Therapy CrossRef